- Home
- GNLX vs CHMI Comparison
GNLX vs CHMI Comparison
Compare GNLX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- CHMI
- Stock Information
- Founded
- GNLX 2001
- CHMI 2012
- Country
- GNLX United States
- CHMI United States
- Employees
- GNLX N/A
- CHMI N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- CHMI Real Estate Investment Trusts
- Sector
- GNLX Health Care
- CHMI Real Estate
- Exchange
- GNLX Nasdaq
- CHMI Nasdaq
- Market Cap
- GNLX 128.0M
- CHMI 105.3M
- IPO Year
- GNLX 2023
- CHMI 2013
- Fundamental
- Price
- GNLX $3.92
- CHMI $3.03
- Analyst Decision
- GNLX Strong Buy
- CHMI Hold
- Analyst Count
- GNLX 4
- CHMI 1
- Target Price
- GNLX $17.75
- CHMI N/A
- AVG Volume (30 Days)
- GNLX 132.9K
- CHMI 239.2K
- Earning Date
- GNLX 11-13-2025
- CHMI 11-11-2025
- Dividend Yield
- GNLX N/A
- CHMI 19.87%
- EPS Growth
- GNLX N/A
- CHMI N/A
- EPS
- GNLX N/A
- CHMI N/A
- Revenue
- GNLX N/A
- CHMI $25,461,000.00
- Revenue This Year
- GNLX N/A
- CHMI N/A
- Revenue Next Year
- GNLX N/A
- CHMI $54.92
- P/E Ratio
- GNLX N/A
- CHMI N/A
- Revenue Growth
- GNLX N/A
- CHMI 3.21
- 52 Week Low
- GNLX $1.95
- CHMI $2.34
- 52 Week High
- GNLX $5.89
- CHMI $3.81
- Technical
- Relative Strength Index (RSI)
- GNLX 62.72
- CHMI 65.69
- Support Level
- GNLX $3.56
- CHMI $2.92
- Resistance Level
- GNLX $3.61
- CHMI $2.92
- Average True Range (ATR)
- GNLX 0.23
- CHMI 0.06
- MACD
- GNLX 0.04
- CHMI 0.01
- Stochastic Oscillator
- GNLX 88.57
- CHMI 95.45
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.